当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析 - 现金流量表

新华医疗

(600587)

  

流通市值:75.47亿  总市值:75.47亿
流通股本:6.07亿   总股本:6.07亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,938,923,383.164,656,606,981.772,104,694,559.449,219,926,033.9
  收到的税费返还4,250,708.563,982,057.363,226,715.9812,764,005.93
  收到其他与经营活动有关的现金214,458,105.51147,937,696.11138,562,696.79256,022,825.72
  经营活动现金流入小计7,157,632,197.234,808,526,735.242,246,483,972.219,488,712,865.55
  购买商品、接受劳务支付的现金4,559,084,736.632,956,737,843.891,245,554,948.575,790,923,266.02
  支付给职工以及为职工支付的现金1,285,804,640.63885,644,034.85511,183,997.341,706,551,621.45
  支付的各项税费427,473,673.54269,029,146.45140,936,880.86418,591,288.93
  支付其他与经营活动有关的现金658,324,831.44432,384,077.33281,145,586.89872,009,768.75
  经营活动现金流出小计6,930,687,882.244,543,795,102.522,178,821,413.668,788,075,945.15
  经营活动产生的现金流量净额226,944,314.99264,731,632.7267,662,558.55700,636,920.4
二、投资活动产生的现金流量:
  收回投资收到的现金6,275,884.784,240,041.872,324,724.0228,705,032.46
  取得投资收益收到的现金5,549,102.255,549,102.25-89,336,819.73
  处置固定资产、无形资产和其他长期资产收回的现金净额3,700,844.396,7304,6301,035,945.75
  处置子公司及其他营业单位收到的现金净额---103,563,260.51
  收到的其他与投资活动有关的现金310,349,944.44---
  投资活动现金流入小计325,875,775.869,795,874.122,329,354.02222,641,058.45
  购建固定资产、无形资产和其他长期资产支付的现金66,381,709.7335,160,031.6218,830,367.55381,549,258.53
  投资支付的现金9,800,0009,800,000-23,944,877.42
  支付其他与投资活动有关的现金716,500,000708,500,000708,000,000-
  投资活动现金流出小计792,681,709.73753,460,031.62726,830,367.55405,494,135.95
  投资活动产生的现金流量净额-466,805,933.87-743,664,157.5-724,501,013.53-182,853,077.5
三、筹资活动产生的现金流量:
  取得借款收到的现金701,694,625.15423,773,740.22301,000,0001,194,730,000
  收到其他与筹资活动有关的现金---22,809,962.71
  筹资活动现金流入小计701,694,625.15423,773,740.22301,000,0001,217,539,962.71
  偿还债务支付的现金806,320,844.57541,813,203.26323,283,990.521,149,833,684.23
  分配股利、利润或偿付利息支付的现金96,357,237.9283,694,859.7413,582,153.7352,942,702.7
  其中:子公司支付给少数股东的股利、利润11,102,8365,542,8364,742,83610,324,000
  支付其他与筹资活动有关的现金14,513,203.0410,967,286.935,207,847.4935,082,064
  筹资活动现金流出小计917,191,285.53636,475,349.93342,073,991.711,537,858,450.93
  筹资活动产生的现金流量净额-215,496,660.38-212,701,609.71-41,073,991.71-320,318,488.22
四、汇率变动对现金及现金等价物的影响-7,186,122.31-5,647,558.24-3,483,751.12-371,650.43
五、现金及现金等价物净增加额-462,544,401.57-697,281,692.73-701,396,197.81197,093,704.25
  加:期初现金及现金等价物余额2,966,856,645.272,966,856,645.272,966,856,645.272,769,762,941.02
  期末现金及现金等价物余额2,504,312,243.72,269,574,952.542,265,460,447.462,966,856,645.27
补充资料:
  净利润-289,313,008.85-528,134,579.86
  资产减值准备-38,747,565.63-78,503,721.65
  固定资产和投资性房地产折旧-98,166,703.01-192,071,005.02
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-98,166,703.01-192,071,005.02
  无形资产摊销-8,446,728.04-20,694,272.32
  长期待摊费用摊销-19,543,711.77-41,487,228.34
  处置固定资产、无形资产和其他长期资产的损失--187,412.37-993,363.98
  固定资产报废损失-232,381.18-1,755,394.88
  财务费用-1,380,669.63-41,777,624.07
  投资损失-24,410,239.63--39,100,637.21
  递延所得税-2,959,163.84--6,891,990.48
  其中:递延所得税资产减少-670,749.42--9,541,473.83
    递延所得税负债增加-2,288,414.42-2,649,483.35
  存货的减少-250,749,656.56-398,244,280.46
  经营性应收项目的减少--497,046,212.49-16,374,680.42
  经营性应付项目的增加--15,221,309.08--639,184,402.26
  现金的期末余额-2,269,574,952.54-2,966,856,645.27
  减:现金的期初余额-2,966,856,645.27-2,769,762,941.02
  现金及现金等价物的净增加额--697,281,692.73-197,093,704.25
公告日期2026-10-312026-08-292026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑